Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vita Polizzi
Observed names:
V Polizzi,
V. Polizzi
Institution:
La Maddalena
Observed institutions:
University of Palermo,
La Maddalena,
University of Palermo
OpenAlex ID:
A5065101606
Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans Syndrome
1998
·
M Musso
, F Porretto
, et al.
·
Lupus
·
76
Palonosetron (Aloxi®) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy
2008
·
Maurizio Musso
, Renato Scalone
, et al.
·
Supportive Care in Cancer
·
50
Crohn’s disease complicated by relapsed extranodal Hodgkin’s lymphoma: prolonged complete remission after unmanipulated PBPC autotransplant
2000
·
M Musso
, F Porretto
, et al.
·
Bone Marrow Transplantation
·
42
Palonosetron and dexamethasone for prevention of nausea and vomiting in patients receiving high-dose chemotherapy with auto-SCT
2009
·
M Musso
, R Scalone
, et al.
·
Bone Marrow Transplantation
·
38
Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease
2001
·
Maurizio Musso
, Ferdinando Porretto
, et al.
·
American Journal of Hematology
·
26
PDF
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI)
2025
·
Massimo Breccia
, Francesca Palandri
, et al.
·
Cancer
·
19
Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation
2004
·
M Musso
, F Porretto
, et al.
·
Bone Marrow Transplantation
·
18
Successful treatment of resistant thrombotic thrombocytopenic purpura/hemolytic uremic syndrome with autologous peripheral blood stem and progenitor (CD34+) cell transplantation
1999
·
M Musso
, F Porretto
, et al.
·
Bone Marrow Transplantation
·
13
Low-dose long-term oral idarubicin in maintenance treatment of elderly acute myeloid leukemia.
1997
·
M Musso
, F Porretto
, et al.
·
PubMed
·
4
Primary Mediastinal B‐cell Lymphoma, a nationwide real‐life retrospective study from Fondazione Italiana Linfomi (FIL)
2023
·
E. Iannitto
, M. Balzarotti
, et al.
·
Hematological Oncology
·
3
PDF
Description of a Clinical Score to Identify PMBL Patients at High Risk of Early-Failure after Rituximab Doxorubicin Back-Bone Chemoimmunotherapy. a FIL Real-World Study
2023
·
Emilio Iannitto
, Monica Balzarotti
, et al.
·
Blood
·
1
PDF
Allogeneic hematopoietic stem cell transplantation for aggressive lymphomas
2014
·
Maurizio Musso
, Renato Scalone
, et al.
·
Drugs and Cell Therapies in Hematology
·
1
Correspondence
1998
·
M Musso
, F Porretto
, et al.
·
Leukemia Research
·
1
68 O - Maintenance low-dose (LD) oral idarubicin (oIDA) in elderly patients (pts) with acute myelogeneous leukemia (AML)
1996
·
M. Musso
, F. Porretto
, et al.
·
European Journal of Cancer
·
1
Novel Conditioning Regimens for Hodgkin‘S and Non-Hodgkin‘S Lymphoma
2014
·
Maurizio Musso
, Ferdinando Porretto
, et al.
·
International Journal of Hematologic Oncology
Oralldarubicin in Maintenance Therapy ofAcute Myeloid Leukemia
2001
·
Maurizio Musso
, Ferdinando Porretto
, et al.
Oral Idarubicin in Maintenance Therapy of Acute Myeloid Leukemia
2001
·
M. Musso
, F. Porretto
, et al.
·
Hämatologie und Bluttransfusion
Show more works
View as search
Works count:
18
Citation count:
293
H-index:
8
I10-index:
8
Year
Topic
Type